K. Bock

Early Experience With Neutralizing Monoclonal Antibody Therapy For COVID-19

J. Hirsch, K. Coppa, I. Nash, 2021, medRxiv.

Efficacy of rituximab in difficult-to-manage autoimmune hepatitis: Results from the International Autoimmune Hepatitis Group

M. Manns, F. Lammert, J. Hodson, 2019, JHEP reports.

Ketamine-induced cholangiopathy in ARDS patients

V. Frochot, E. Letavernier, J. Correas, 2021, Intensive Care Medicine.

Intravenous ketamine is a risk factor for jaundice in Covid-19 patients

V. Frochot, E. Letavernier, J. Correas, 2021, Journal of Hepatology.

What is the effect of nicotinic acetylcholine receptor stimulation on osteoarthritis in a rodent animal model?

C. Peck, K. Reimers, V. Coger, 2016, SAGE open medicine.

Role of MRI in Detection of Morton’s Neuroma

C. Stukenborg-Colsman, C. Plaass, H. Waizy, 2014, Foot & ankle international.

Intravenous ketamine and progressive cholangiopathy in COVID-19 patients

V. Frochot, E. Letavernier, J. Correas, 2021, Journal of Hepatology.

Reply to: “Progressive cholangiopathy in COVID-19 patients: Other possible diagnoses than ketamine-induced cholangiopathy should be considered”

V. Frochot, E. Letavernier, J. Correas, 2021, Journal of Hepatology.